Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-006686-32-ES
EUCTR2007-006686-32-ES
Active, not recruiting
Not Applicable

Identificación de biomarcadores proteicos asociados a resistencia a la aspirina y a tienopiridinas en pacientes con cardiopatía isquémica establecida. (ESTUDIO BIRAT).Identification of new protein biomarkers associated with aspirin and thienopyridine resistance in stable coronary ischaemic patients: a proteomic study. (BIRAT Study). - BIRAT

FUNDACIÓN INVESTIGACIÓN BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS0 sitesMarch 27, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsprasugrelCLOPIDOGREL

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
FUNDACIÓN INVESTIGACIÓN BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 27, 2008
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
FUNDACIÓN INVESTIGACIÓN BIOMEDICA DEL HOSPITAL CLINICO SAN CARLOS

Eligibility Criteria

Inclusion Criteria

  • •\-Men and women, ages 18 or older
  • •\-Documented history of coronary disease define as \>50% stenosis in \>/\= 1 major coronary artery, clinically stable for at least 6 months.
  • •\-Stable clinical situation at least during the last month.
  • •\-Patients receiving AAS 100 mg daily at least during the last month and with the last AAS dosage 24 hours before
  • •\-Written consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • •\-Another antithrombotic treatment than AAS in the previous month
  • •\-Presence of active infectious or tumoral disease
  • •\-Recent trauma or major surgery, angioplasty or cathetherism during the last month
  • •\-Atorvastatin treated patients
  • •\-Patients receiving antiinflammatory treatment during the last month
  • •\-No written consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Proteomic analysis for establishing a biomarker panel for the onset of Adult T-cell Leukemia (ATL)
JPRN-UMIN000038467niversity of the Ryukyus85
Recruiting
Not Applicable
Identification of Protein markers in ovarian cancerOvarian CancerCancer - Ovarian and primary peritoneal
ACTRN12608000519358Ovarian cancer research fund100
Active, not recruiting
Not Applicable
Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensión arterial no controlada y disfunción ventricular sistólica leve”Identification of proteomic biomarkers associated with eplerenone treatment versus spironolactone in post-acute coronary syndrome patients, with non-controlled arterial hypertension and ventricular dysfunction - PROMETEODisfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada.Low-moderate ventricular dysfunction in post-acute coronary syndrome patients with diabetes and non-controlled arterial hypertension.
EUCTR2008-001192-29-ESFundación Investigación y Desarrollo en el Area Cardiovascular
Not yet recruiting
Not Applicable
Application of proteomics to aid biomarker discovery in smear positive patients of P.vivax and P.falciparum malaria
CTRI/2010/091/000451Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), Powai, Mumbai- 400 076100
Recruiting
Not Applicable
Identification of Blood Biomarkers Associated with Cardiac Remodeling after Myocardial Infarctio
JPRN-UMIN000045598Graduate School of Medicine and Faculty of Medicine, The University of Tokyo200